Demand for weight loss medications such as Ozempic and Wegovy has skyrocketed in recent years, despite their high cost and unpleasant side effects for some people. The New York Times reports that some patients are finding a way around both concerns by experimenting with microdosing the drugs. Dr. Jeremy Faust, an emergency physician at Brigham and Women’s Hospital in Boston, joins CBS News to assess the safety and risks of the practice.